secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001104659-26-020643
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie prices $8B multi-tranche senior note offering; net proceeds ~$7.95B
--------------------------------------------------------------------------

- Issued $8.0B in senior notes across seven tranches (2028–2066), rates from floating to 5.650%.
- Net proceeds ~$7.95B; $2B to repay outstanding term loan due May 2026; remainder for general corporate purposes.
- Underwriting syndicate led by J.P. Morgan, BofA, Morgan Stanley, Wells Fargo; closing expected March 4, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465926020643/0001104659-26-020643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465926020643/tm266774d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-020643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer